Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson's disease

Neurobiology of Disease

Volumn 20, Issue 1, 2005, Pages 93-103

  Bassilana, F ^a   MacE, N ^a   Li, Q ^b   Stutzmann, J M ^a   Gross, C E ^c   Pradier, L ^a   Benavides, J ^a   Menager J ^a   Bezard, E ^c  

^a SANOFI   (France)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

^c CNRS   (France)

Author keywords

Affymetrix; Microarray; Neurodegeneration; Nonhuman primate; RT PCR

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; SODIUM CHLORIDE;

ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LOSS; CLUSTER ANALYSIS; CONTROLLED STUDY; DEGENERATION; DEREGULATION; DISEASE COURSE; DOPAMINERGIC NERVE CELL; FEMALE; GENE EXPRESSION; GENE SEQUENCE; MACACA; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BRAIN CHEMISTRY; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MACACA FASCICULARIS; NERVE DEGENERATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARKINSONIAN DISORDERS; RNA, MESSENGER; SUBSTANTIA NIGRA; TRANSCRIPTION, GENETIC;

EID: 24044535094     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2005.02.005     Document Type: Article

References (35)

1. A. Bagri, O. Marin, A.S. Plump, J. Mak, S.J. Pleasure, J.L. Rubenstein, and M. Tessier-Lavigne Slit proteins prevent midline crossing and determine the dorsoventral position of major axonal pathways in the mammalian forebrain Neuron 33 2002 233 248
2. D. Berg, M. Gerlach, MB. Youdim, KL. Double, L. Zecca, P. Riederer, and G. Becker Brain iron pathways and their relevance to Parkinson's disease J. Neurochem. 79 2001 225 236
3. H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K. Jellinger, and F. Seitelberger Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations J. Neurol. Sci. 20 1973 415 455
4. E. Bezard, C. Imbert, X. Deloire, B. Bioulac, and C.E. Gross A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey Brain Res. 766 1997 107 112
5. E. Bezard, T. Boraud, B. Bioulac, and C.E. Gross Involvement of the subthalamic nucleus in glutamatergic compensatory mechanisms Eur. J. Neurosci. 11 1999 2167 2170
6. E. Bezard, A.R. Crossman, C.E. Gross, and J.M. Brotchie Structures outside the basal ganglia may compensate for dopamine loss in the presymptomatic stages of Parkinson's disease FASEB J. 15 2001 1092 1094
7. E. Bezard, P. Ravenscroft, C.E. Gross, A.R. Crossman, and J.M. Brotchie Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl- 1,2,3,6- tetrahydropyridine monkeys Neurobiol. Dis. 8 2001 343 350
8. E. Bezard, S. Dovero, C. Prunier, P. Ravenscroft, S. Chalon, D. Guilloteau, A.R. Crossman, B. Bioulac, J.M. Brotchie, and C.E. Gross Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- lesioned macaque model of Parkinson's disease J. Neurosci. 21 2001 6853 6861
9. E. Bezard, C.E. Gross, and J.M. Brotchie Presymptomatic compensation in Parkinson's disease is not dopamine-mediated Trends Neurosci. 26 2003 215 221
10. D. Blum, S. Torch, N. Lambeng, M. Nissou, A.L. Benabid, R. Sadoul, and J.M. Verna Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Prog. Neurobiol. 65 2001 135 172
11. G. Castelo-Branco, J. Wagner, F.J. Rodriguez, J. Kele, K. Sousa, N. Rawal, H.A. Pasolli, E. Fuchs, J. Kitajewski, and E. Arenas Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a Proc. Natl. Acad. Sci. U. S. A. 100 2003 12747 12752
12. T.M. Dawson, and V.L. Dawson Molecular pathways of neurodegeneration in Parkinson's disease Science 302 2003 819 822
13. T.M. Dawson, and V.L. Dawson Rare genetic mutations shed light on the pathogenesis of Parkinson disease J. Clin. Invest. 111 2003 145 151
14. B.I. Giasson, and V.M. Lee Parkin and the molecular pathways of Parkinson's disease Neuron 31 2001 885 888
15. E. Grunblatt, S. Mandel, G. Maor, and M.B. Youdim Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine J. Neurochem. 78 2001 1 12
16. R. Hassler Zur Pathologie der Paralysis Agitans und des postenzephalitischen Parkinsonismus J. Psychol. Neurol. 48 1938 387 476
17. M.M. Hoehn, and M.D. Yahr Parkinsonism: onset, progression and mortality Neurology 17 1967 427 442
18. Y. Imai, M. Soda, H. Inoue, N. Hattori, Y. Mizuno, and R. Takahashi An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin Cell 105 2001 891 902
19. Y. Imai, M. Soda, T. Murakami, M. Shoji, K. Abe, and R. Takahashi A product of the human gene adjacent to parkin is a component of Lewy bodies and suppresses pael receptor-induced cell death J. Biol. Chem. 278 2003 51901 51910 (Electronic publication 52003 Oct 51907)
20. V. Jackson-Lewis, M. Jakowec, R.E. Burke, and S. Przedborski Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurodegeneration 4 1995 257 269
21. A. Kasprzyk, D. Keefe, D. Smedley, D. London, W. Spooner, C. Melsopp, M. Hammond, P. Rocca-Serra, T. Cox, and E. Birney EnsMart: a generic system for fast and flexible access to biological data Genome Res. 14 2004 160 169
22. K.S. Kim, C.H. Kim, D.Y. Hwang, H. Seo, S. Chung, S.J. Hong, J.K. Lim, T. Anderson, and O. Isacson Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner J. Neurochem. 85 2003 622 634
23. T. Klockgether, and B. Evert Genes involved in hereditary ataxias Trends Neurosci. 21 1998 413 418
24. W. Le, O.M. Conneely, Y. He, J. Jankovic, and S.H. Appel Reduced Nurr1 expression increases the vulnerability of mesencephalic dopamine neurons to MPTP-induced injury J. Neurochem. 73 1999 2218 2221
25. W.D. Le, P. Xu, J. Jankovic, H. Jiang, S.H. Appel, R.G. Smith, and D.K. Vassilatis Mutations in NR4A2 associated with familial Parkinson disease Nat. Genet. 33 2003 85 89
26. C.S.W.C.Y. Lu, P.C. Kuo, H.C. Chang, and Y.H. Weng The parkinsonian phenotype of spinocerebellar ataxia type 2 Arch. Neurol. 61 2004 35 38
27. R.F. Martin, and D.M. Bowden A stereotaxic template atlas of the macaque brain for digital imaging and quantitative neuroanatomy NeuroImage 4 1996 119 150
28. M. Marvanova, J. Menager, E. Bezard, R.E. Bontrop, L. Pradier, and G. Wong Microarray analysis of nonhuman primates: validation of experimental models in neurological disorders FASEB J. 17 2003 929 931
29. W. Meissner, M.P. Hill, F. Tison, C.E. Gross, and E. Bezard Neuroprotective strategies for Parkinson's disease: conceptual limits of clinical trials and animal models Trends Pharmacol. Sci. 25 2004 249 253
30. R.M. Miller, L.M. Callahan, C. Casaceli, L. Chen, G.L. Kiser, B. Chui, T.M. Kaysser-Kranich, T.J. Sendera, C. Palaniappan, and H.J. Federoff Dysregulation of gene expression in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-lesioned mouse substantia nigra J. Neurosci. 24 2004 7445 7454
31. T. Murakami, M. Shoji, Y. Imai, H. Inoue, T. Kawarabayashi, E. Matsubara, Y. Harigaya, A. Sasaki, R. Takahashi, and K. Abe Pael-R is accumulated in Lewy bodies of Parkinson's disease Ann. Neurol. 55 2004 439 442
32. M.P. Smidt, S.M. Smits, and J.P. Burbach Molecular mechanisms underlying midbrain dopamine neuron development and function Eur. J. Pharmacol. 480 2003 75 88
33. J. Szabo, and W.M. Cowan A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis) J. Comp. Neurol. 222 1984 265 300
34. Y. Takeuchi, and K. Fukunaga Differential subcellular localization of two dopamine D2 receptor isoforms in transfected NG108-15 cells J. Neurochem. 85 2003 1064 1074
35. M.J. Zigmond, E.D. Abercrombie, T.W. Berger, A.A. Grace, and E.M. Stricker Compensations after lesions of central dopaminergic neurons: some clinical and basic implications Trends Neurosci. 13 1990 290 296